Delivery Order SPE2DB20D9214-SPE2DB25FD4XM
- Not listed
- The Defense Logistics Agency awarded a $27,853.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 150 mg/ml Xolair syringes. The contract, awarded September 17, 2025, with an ultimate completion date of October 8, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,209.60 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 mL syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by June 11, 2025, with performance taking place at the contractor's Park Ridge facility. This award was issued under...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order for XOLAIR 150 MG/ML syringes valued at $3,094.80. The contract, which was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, carries firm fixed-price terms and does not utilize a set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,605.50 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, and the contract carries no set-aside designation. The delivery order is scheduled for completion by September 24, 2025, and represents a single purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,284.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 mL syringes. The contract, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a $4,642.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The contract, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes valued at $12,379.20. This firm fixed-price delivery order, issued on September 9, 2025, is expected to be completed by September 30, 2025, and operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,474 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA under the SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 10, 2025, is scheduled for ultimate completion by October 1, 2025, with performance taking place at the awardee's Park Ridge facility. The contract was awarded without a set-aside designation,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,094.80 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its Park Ridge location with an ultimate completion date of October 2, 2025. This delivery order was issued without a set-aside designation, leveraging the company's competitive capabilities...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4XMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,568.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Xolair 150 mg/1.2 mL powder vials. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, contains no set-aside designation. The contract represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facility supply chains nationwide. Xolair (omalizumab) is a biologic medication primarily used for severe allergic asthma and other allergic conditions, and this procurement supports the Department of Defense's medical supply requirements across its healthcare system. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical distribution network, leveraging its woman-owned small business status to compete effectively while maintaining a robust portfolio of branded and generic medications, biologics, and medical consumables. The delivery order pricing reflects firm fixed-price terms typical of DLA pharmaceutical procurement vehicles, ensuring predictable costs for government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 9/3/25 |